NBCSN Nationally Certified School Nurse Practice Exam

When should the meningococcal vaccine (Menactra) be administered?

1. 6 months

2. 9-10 years

3. 11-12 years

4. 14-15 years

The correct answer is: 11-12 years

The meningococcal vaccine, commonly known as Menactra, is recommended to be administered to adolescents at the ages of 11 to 12 years. This timing is crucial as it helps ensure that preteens are protected against meningococcal disease before entering high-risk environments, such as middle and high school, where outbreaks can occur more frequently. Additionally, a booster dose is typically given at 16 years of age, reinforcing the protection as adolescents age into young adulthood. The vaccination schedule is designed to align with developmental milestones and increasing exposure to potential pathogens, which is evident in the recommendation for the 11-12 year age group. This approach not only maximizes immunity but also helps in public health initiatives aimed at reducing the incidence of meningococcal disease within the community.